- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 2nd, 2006
GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-Bang(TM), a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province.
Using state-of-art nanotechnology, Gu-Bang(TM) is chemically synthesized to create porous, biodegradable and rigid granules. The material, which is non-toxic, non-irritant and has excellent biocompatibility, does not contain proteins, DNA or endotoxins found in allografts, thus avoiding the risk of abnormal allergic and immunologic reactions following implantation.
|Related News Press|
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016
PEN Inc. Announces Strategy to Broaden Clarity Branded Products Business February 4th, 2016
Graphenea increases capacity, reduces prices January 25th, 2016
NREL finds nanotube semiconductors well-suited for PV systems April 27th, 2016
Atomic magnets using hydrogen and graphene April 27th, 2016
Superfast light source made from artificial atom April 28th, 2016